Jiří Špaček

2.5k total citations
23 papers, 95 citations indexed

About

Jiří Špaček is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiří Špaček has authored 23 papers receiving a total of 95 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiří Špaček's work include Cancer Immunotherapy and Biomarkers (4 papers), Reproductive tract infections research (3 papers) and Herbal Medicine Research Studies (2 papers). Jiří Špaček is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Reproductive tract infections research (3 papers) and Herbal Medicine Research Studies (2 papers). Jiří Špaček collaborates with scholars based in Czechia, Australia and Germany. Jiří Špaček's co-authors include Vladimı́r Buchta, Michal Vočka, B Konopásek, Eva Závadová, Luboš Petruželka, Helena Skálová, Pavel Dundr, Marcela Vejsová, Marcela Drahošová and L Chrobák and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Cancer Research and Clinical Oncology and Mycoses.

In The Last Decade

Jiří Špaček

19 papers receiving 88 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiří Špaček Czechia	6	30	24	17	14	14	23	95
Tomás Zecchini Barrese Brazil	4	47 1.6×	40 1.7×	22 1.3×	5 0.4×	8 0.6×	13	98
August Bier Germany	4	28 0.9×	54 2.3×	20 1.2×	5 0.4×	10 0.7×	9	151
Sterling Wu United States	4	23 0.8×	30 1.3×	28 1.6×	12 0.9×	19 1.4×	10	215
Mei‐Qi Zheng China	7	27 0.9×	14 0.6×	75 4.4×	3 0.2×	10 0.7×	11	165
Chris Hawkey United Kingdom	2	9 0.3×	33 1.4×	29 1.7×	23 1.6×	5 0.4×	3	106
Toshinori Moriguchi Japan	6	21 0.7×	45 1.9×	24 1.4×	2 0.1×	25 1.8×	7	109
Pooja Datt United Kingdom	3	29 1.0×	41 1.7×	21 1.2×	2 0.1×	4 0.3×	4	80
Christoph Noppen Switzerland	5	23 0.8×	7 0.3×	32 1.9×	4 0.3×	17 1.2×	7	112
Saba Azarnoush France	7	35 1.2×	120 5.0×	24 1.4×	7 0.5×	10 0.7×	10	207
Hirotoshi Sugino Japan	6	9 0.3×	29 1.2×	30 1.8×	14 1.0×	11 0.8×	9	82

Countries citing papers authored by Jiří Špaček

Since Specialization

Citations

This map shows the geographic impact of Jiří Špaček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Špaček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Špaček more than expected).

Fields of papers citing papers by Jiří Špaček

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Špaček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Špaček. The network helps show where Jiří Špaček may publish in the future.

Co-authorship network of co-authors of Jiří Špaček

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Špaček. A scholar is included among the top collaborators of Jiří Špaček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Špaček. Jiří Špaček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benešová, Iva, et al.. (2024). Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors. Journal of Cancer Research and Clinical Oncology. 150(2). 99–99. 4 indexed citations

Študentová, Hana, Bohuslav Melichar, Alexandr Poprach, et al.. (2024). Avelumab first-line maintenance (1LM) in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in the Czech Republic: Interim real-world results from a national reimbursement registry.. Journal of Clinical Oncology. 42(4_suppl). 557–557.

Werner, Lukáš, Jan Štursa, Vladimír Černý, et al.. (2023). Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial. Therapeutic Advances in Medical Oncology. 15. 2642693–2642693. 5 indexed citations

Špaček, Jiří, Michal Vočka, Eva Závadová, B Konopásek, & Luboš Petruželka. (2021). Immunomodulation with β-Glucan from Pleurotus Ostreatus in Patients with Endocrine-Dependent Breast Cancer. Immunotherapy. 14(1). 31–40. 6 indexed citations

Petruželka, Luboš, et al.. (2021). Future of lung cancer treatment. Klinicka onkologie. 34(Suppl 1). 71–81. 2 indexed citations

Špaček, Jiří. (2020). Gastrointestinal Toxicity of Immunotherapy. Klinicka onkologie. 33(1). 23–28. 3 indexed citations

Andreas, Michal, et al.. (2019). Endangered aquatic macrophytes in the diet of rudd (Scardinius erythrophthalmus). Folia Zoologica. 68(1). 1–1. 2 indexed citations

Špaček, Jiří, Michal Vočka, Helena Skálová, et al.. (2018). Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controls. Immunological Investigations. 47(7). 643–653. 19 indexed citations

Špaček, Jiří, et al.. (2015). Page kidney - pozdní prezentace subkapsulárního hematomu ledviny u mladého chlapce. 19(3). 229–232.

10.

Závadová, Eva, Jiří Špaček, Michal Vočka, et al.. (2015). http://www.linkos.cz/klinicka-onkologie-journal/search-for-articles/skupina/a/zobrazit/ids/4854/. Klinicka onkologie. 28(Suppl 4). 4S82–4S85. 2 indexed citations

11.

Špaček, Jiří, et al.. (2013). Individual single-site travel cost model for Czech paradise geopark. Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis. 61(7). 2851–2858. 8 indexed citations

12.

Buchta, Vladimı́r, et al.. (2013). [Is diabetes mellitus a risk factor in genital yeast infections?].. PubMed. 78(6). 537–44. 4 indexed citations

13.

Sedláková, Iva, et al.. (2010). [Resistance/sensitivity in vitro in ovarian cancer patients].. PubMed. 75(3). 182–7. 1 indexed citations

14.

Šufliarský, Jozef, Jozef Chovanec, Daniela Světlovská, et al.. (2009). Gemcitabine and carboplatin treatment in Patients with relapsing ovarian cancer. Neoplasma. 56(4). 291–297. 4 indexed citations

15.

Sikora, Jakub, et al.. (2007). A case of excessive autophagocytosis with multiorgan involvement and low clinical penetrance.. PubMed. 43(3). 93–103. 1 indexed citations

16.

Špaček, Jiří, et al.. (2006). [Primitive nonneural granular cell tumor of skin (case report)].. PubMed. 42(4). 191–3. 1 indexed citations

17.

Špaček, Jiří & Vladimı́r Buchta. (2005). Itraconazole in the treatment of acute and recurrent vulvovaginal candidosis: comparison of a 1‐day and a 3‐day regimen. Mycoses. 48(3). 165–171. 10 indexed citations

18.

Jílek, Petr, et al.. (2005). [Systemic immunity in patients with recurrent vulvovaginal candidiasis].. PubMed. 70(6). 453–9. 5 indexed citations

19.

Špaček, Jiří, et al.. (2005). [Chlamydia infections in urogenital tract--application of direct immunofluorescence in the diagnostics of Chlamydia trachomatis in the East Bohemian Region of Czech Republic during 1997-2003].. PubMed. 70(2). 128–33. 1 indexed citations

20.

Špaček, Jiří, et al.. (2000). [Fetal rhabdomyoma of the mucosa of the lip (case report)].. PubMed. 36(1). 21–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact